Skip to content

Effects of Lumber Sustained Natural Apophyseal Glides on Lower Cross Syndrome

Effects of Lumber Sustained Natural Apophyseal Glides on Lower Cross Syndrome

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06707805
Enrollment
36
Registered
2024-11-27
Start date
2024-05-01
Completion date
2025-03-31
Last updated
2025-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Cross Syndrome

Keywords

pain, lumber SNGS

Brief summary

A sustained natural apophyseal glide (SNAG) is a mobilization technique commonly used in the treatment of painful movement restrictions of the spine.Studing the effect of Lumber SNAGs in lower cross syndrome hold significance due to its potential to correct pain, hypomobility and biomechanical changes i.e hyperlordotic curve and anterior pelvic tilting caused by lower cross syndrome. The specific muscle imbalance seen in PCS gives rise to specific joint dysfunction, particularly in the L4-L5 and L5-S1 segment of the vertebral column. Over time, this causes stress at the L5-S1 segment of the vertebral column leading to pain and irritation in the lower back Lumber SNAGs encourage improvement of these repositioning error, posture, alleviate discomfort and enhance overall functioning. This research aims to offer patients a noninvasive and personalized approach to managing LCS, ultimately contributing to their overall well-being and movement quality

Detailed description

A sustained natural apophyseal glide (SNAG) is a mobilization technique commonly used in the treatment of painful movement restrictions of the spine.Studing the effect of Lumber SNAGs in lower cross syndrome hold significance due to its potential to correct pain, hypomobility and biomechanical changes i.e hyperlordotic curve and anterior pelvic tilting caused by lower cross syndrome. The specific muscle imbalance seen in PCS gives rise to specific joint dysfunction, particularly in the L4-L5 and L5-S1 segment of the vertebral column. Over time, this causes stress at the L5-S1 segment of the vertebral column leading to pain and irritation in the lower back Lumber SNAGs encourage improvement of these repositioning error, posture, eleviate discomfort and enhance overall functioning. This research aims to offer patients a noninvasive and personalized approach to managing LCS, ultimately contributing to their overall well-being and movement quality The significance of this study lies in it's potential to improve the health and wellbeing of adults have pain and hypomobility due to lower cross syndrome.By identifying an effective physical therapy intervention for correcting pain and hypomobility , this study provide valueable insight for clinicians in develping effective treatment strategies.

Interventions

OTHERTraditional Physical therapy

Conventional treatment protocol including moist Heating pad for low back pain for 15 minutes. TENS for pain for 10 minutes. Stretchings of tight muscles would be 1 set of 5-7 reps with 5 sec. hold 3 times a week. Strengthing of weak muscles would be 2-3 times a weak with 10-15 reps.Stretching protocol will be followed for Iliopsoas and erector spinae muscles. Strengthening protocol will be followed for weak abdominals and Gluteus maximus muscles

OTHERlumber SNAGS

: Lumber mobilizations with conventional treatment protocol. * Lumber Mulligan(SNAGs) technique * Technique applied at L4-L5, L5-S1 level. * Techniques applied for flexion ,extension, side bending and rotation 6 to 8 cycles per session

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 30 to 50 years. * Both genders * Patient came with the complain of low back pain. * Participants had to present with pain and hypomobility due to lower cross syndrome * Participants had to meet the criteria for lower cross syndrome indicating tight hip flexors and erector spinae along with weak abdominals and glutei muscles * Participants with hyperlordotic curve due to lower cross syndrome * Participants presenting with anterior pelvic tilting greater than angle \>7-10 degrees * Willing to provide informed consent to participate in study

Exclusion criteria

Participants contraindicated to spinal manipulation * Musculoskeletal pathologies affecting the lower back, pelvis, hips, or lower extremities (e.g., herniated disc, lumbar radiculopathy, lumbar stenosis, hip labral tear). * Participants who had undergone any lumber or pelvic surgery, as it will affect sacroiliac joint mechanics. * Generalized inflammatory or infective connective tissue disorder * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Oswestry disability indexfrom baseline to 4th weekThe Oswestry Low Back Pain Disability Questionnaire is an adequate apparatus used to measure disability caused by low back pain in the general population. The questionnaire examines the level of disability in 10 everyday activities of daily living. Each item consist of 6 statements which are scored from 0 to 5. With 0 indicating the least disability and 5 the greatest then the total score is calculated as a percentage, with 0% indicating no disability and 100% indicating the highest level of disability.

Secondary

MeasureTime frameDescription
Numeric pain rating saclefrom baseline to 4th weekThe Numerical Rating Scale (Appendix G) is one of the most commonly used tools to measure pain intensity in both clinical and research settings. The Numerical Rating Scale is an 11-point scale that consists of numbers from 0 to 10, 0 signifies no pain and 10 signifies worst imaginable pain
Lumber Range of motionAT baseline and 3rd weekto test hypomobility in Lumber Spine with the help of Inclinometer

Countries

Pakistan

Contacts

Primary ContactAsmar Fatima, MS-OMPT
asmar.fatima@riphah.edu.pk03336195644

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026